News Pharma Industry

WHO recommends 2nd Malaria vaccine R21/Matrix-M made by Oxford-Serum Institute; says cheap, more effective – The Economic Times Video


The R21/Matrix-M malaria vaccine developed by the University of Oxford and the Serum Institute of India has been recommended for use by the World Health Organisation (WHO) after meeting required safety, quality and effectiveness standards. Following a rigorous, detailed scientific review by the WHO’s independent advisory body, the Strategic Advisory Group of Experts (SAGE) and the Malaria Policy Advisory Group (MPAG), the R21/Matrix-M malaria vaccine has been recommended for use.


Source link